Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0760
D

Significant Medication Error Due to Incorrect PRN Methocarbamol Administration

Charlton, Massachusetts Survey Completed on 05-15-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when the facility failed to ensure that a resident was free from significant medication errors. Specifically, the resident, who had a history of hemiplegia and hemiparesis following a cerebral infarction, had physician orders for Methocarbamol 500 mg to be administered as needed (PRN) once daily for muscle spasm, and a separate order for Methocarbamol 500 mg to be given twice daily for pain/spasm. Review of the Medication Administration Records (MAR) revealed that the PRN Methocarbamol was administered more frequently than ordered, with doses given twice daily on multiple dates, rather than the prescribed once daily. Interviews with the Unit Manager and Director of Nursing confirmed that the PRN Methocarbamol was administered outside the parameters of the physician's orders, resulting in a significant medication error. The error was identified through record review and staff interviews, which indicated that the medication was given too close to the scheduled doses, contrary to the physician's instructions.

An unhandled error has occurred. Reload 🗙